Evidence that the inhibitory effects of guanidinoacetate on the activities of the respiratory chain, Na+,K+-ATPase and creatine kinase can be differentially prevented by taurine and vitamins E and C administration in rat striatum in vivo

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1772, Issue 5, 2007, Pages 563-569

  Zugno, Alexandra I ^a   Scherer, Emilene B S ^a   Mattos, Cristiane ^a   Ribeiro, César A J ^a   Wannmacher, Clovis M D ^a   Wajner, Moacir ^a   Wyse, Angela T S ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

GAMT deficiency; Guanidinoacetate; Metabolic disease; Respiratory chain; Taurine; Vitamins E and C

Indexed keywords

ACETIC ACID; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ALPHA TOCOPHEROL; ASCORBIC ACID; CARBON 14; CARBON DIOXIDE; CREATINE KINASE; GLUCOSE; GUANIDINOACETATE METHYLTRANSFERASE; GUANIDINOACETIC ACID; TAURINE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CORPUS STRIATUM; DEMENTIA; ENERGY METABOLISM; ENZYME ACTIVITY; ENZYME DEFICIENCY; EPILEPSY; MENTAL DEFICIENCY; MITOCHONDRIAL RESPIRATION; NEUROLOGIC DISEASE; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; CARBON DIOXIDE; CORPUS STRIATUM; CREATINE KINASE; DRUG ADMINISTRATION ROUTES; ELECTRON TRANSPORT; GLYCINE; LIPID PEROXIDATION; NA(+)-K(+)-EXCHANGING ATPASE; OXIDATIVE STRESS; RATS; RATS, WISTAR; TAURINE; VITAMIN E; VITAMINS;

RATTUS;

EID: 34247104497     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2007.02.005     Document Type: Article

References (49)

1. Von Figura K., Hanefeld F., Isbrandt D., and Stöckler-Ipsiroglu S. Guanidinoacetate methyltransferase deficiency. In: Scriver C.R., Beaudet A.L., Sly W.S., and Valle D. (Eds). The Metabolic and Molecular Bases of Inherited Disease. 8th ed. (2001), McGraw-Hill, New York 1897-1908
2. Schulze A., Ebinger F., Rating D., and Mayaetepek E. Improving treatment of guanidinoacetate methyltransferase deficiency: reduction of guanidinoacetic acid in body fluids by arginine restriction and ornithine supplementation. Mol. Genet. Metab. 74 (2001) 413-419
3. A receptors by guanidinoacetate: a novel pathophysiological mechanism. Neurobiol. Dis. 11 (2002) 298-307
4. Hiramatsu M., Ohba S., Edamatsu R., Kadowari D., and Mori A. Effect of guanidino compounds on membrane fluidity of rats synaptosomes. In: De Deyn P.P., Marescau I.A., Quereshi S.D., and Mori A. (Eds). Guanidino Compounds in Biology and Medicine vol. 1 (1992), John Libbey and Company Lta, Guildford, UK 387-393
5. Schulze A. Creatine deficiency syndromes. Mol. Cell. Biochem. 244 (2003) 143-150
6. Sykut-Cegielska J., Gradowska W., Mercimek-Mahmutoglu S., and Stockler-Ipsiroglu S. Biochemical and clinical characteristics of creatine deficiency syndromes. Acta Biochim. Pol. 51 (2004) 875-882
7. Heales S.J.R., Bolaños J.P., Stewart V.C., Brookes P.S., Land J.M., and Clark J.B. Nitric oxide, mitochondria and neurological disease. Biochim. Biophys. Acta 1410 (1999) 215-228
8. Brennan W.A., Bird E.D., and Aprille J.R. Regional mitochondrial respiratory activity in Huntington's disease brain. J. Neurochem. 44 (1985) 1948-1950
9. Blass J.P. Brain metabolism and brain disease: is metabolic deficiency the proximate cause of Alzheimer dementia?. J. Neurosci. Res. 66 (2001) 851-856
10. Schurr A. Energy metabolism, stress hormones and neural recovery from cerebral ischemia/hypoxia. Neurochem. Int. 41 (2002) 1-8
11. Onyango I.G., and Khan S.M. Oxidative stress, mitochondrial dysfunction and stress signaling in Alzheimer disease. Curr. Alzheimer Res. 3 (2006) 339-349
12. Chinta S.J., and Andersen J.K. Reversible inhibition of mitochondrial complex I activity following chronic dopaminergic glutathione depletion in vitro: implications for Parkinson's disease. Free Radic. Biol. Med. 41 (2006) 1442-1448
13. Schimidt A., Marescau B., Boehm E.A., Renema W.K.J., Peco R., Das A., Steinfeld R., Chan S., Wallis J., Davidoff M., Ullrich K., Waldschütz R., Heerscharp A., De Deyn P.P., Neubauer S., and Isbrandt D. Severely altered guanidino compound levels, disturbed body weight homeostasis and impaired fertility in a mouse model of guanidinoacetate N-methyltransferase (GAMT) deficiency. Hum. Mol. Genet. 13 (2004) 905-921
14. Zugno A.I., Scherer E.B., Schuck P.F., Oliveira D.L., Wofchuk S., Wannmacher C.M.D., Wajner M., and Wyse A.T.S. Intrastriatal administration of guanidinoacetate inhibits Na+, K+-ATPase and creatine kinase activities in rat striatum. Metab. Brain Dis. 21 (2006) 41-50
15. Halliwell B. Oxidative stress and neurodegeneration: where are we now?. J. Neurochem. 97 (2006) 1634-1658
16. Halliwell B. Role of free radicals in the neurodegenerative diseases. Therapeutic implications for antioxidant treatment. Drug Aging 18 (2001) 685-716
17. Spence J.D. Nutrition and stroke prevention. Stroke 37 (2006) 2430-2435
18. Sener G., Sehirli A.O., Ipci Y., Cetinel S., Cikler E., Gedik N., and Alican I. Taurine treatment protects against chronic nicotine-induced oxidative changes. Fundam. Clin. Pharmacol. 19 (2005) 155-164
19. Oriyanhan W., Yamazaki K., Miwa S., Takaba K., Ikeda T., and Komeda M. Taurine prevents myocardial ischemia/reperfusion-induced oxidative stress and apoptosis in prolonged hypothermic rat heart preservation. Heart Vessels 20 (2005) 278-285
20. +-ATPase activity. Int. J. Dev. Neurosci. 22 (2004) 191-196
21. Huxtable R., and Larid H. The prolonged anticonvulsivant action of taurine on genetically determined seizure-susceptibility. Can. J. Neurol. 5 (1978) 215-221
22. Bergamini L., Mutani R., Delsedime M., and Durelli L. First clinical experience on the antiepileptic action of taurine. Neurology 11 (1974) 261-269
23. In: Paxinos G., and Watson C. (Eds). The Rat Brain in Stereotaxic Coordinates. second ed. (1986), Academic Press, San Diego
24. +-ATPase activity in hippocampus of rats subjected to acute administration of homocysteine is prevented by vitamins E and C treatment. Neurochem. Res. 27 (2002) 1685-1689
25. Jones D.H., and Matus A.I. Isolation of plasma synaptic membrane from brain by combination flotation-sedimentation density gradient centrifugation. Biochim. Biophys. Acta 356 (1974) 276-287
26. +-ATPase in synaptic plasma membranes from cerebral cortex of rats. Biochem. Soc. Trans. 23 (1995) 227
27. Fischer J.C., Ruitenbeek W., Berden J.A., Trijbels J.M., Veerkamp J.H., Stadhouders A.M., Sengers R.C., and Janssen A.J. Differential investigation of the capacity of succinate oxidation in human skeletal muscle. Clin. Chim. Acta 153 (1985) 23-36
28. Birch-Machin M.A., Briggs H.L., Saborido A.A., Bindoff L.A., and Turnbull D.M. An evaluation of the activities of complex I-IV in the respiratory chain of human skeletal muscle mitochondria. Biochem. Med. Metab. Biol. 51 (1994) 35-42
29. Rustin P., Chretien D., Bourgeron T., Gérard B., Rötig A., Saudubray J.M., and Munnich A. Biochemical and molecular investigations in respiratory chain deficiencies. Clin. Chim. Acta 228 (1994) 35-51
30. Brusque A.M., Rosa R.B., Schuck P.F., Dalcin K.B., Ribeiro C.A.J., Silva C.G., Wannmacher C.M.D., Dutra-Filho C.S., Wyse A.T.S., Briones P., and Wajner M. Inhibition of the mitochondrial respiratory chain complex activities in rat cerebral cortex by methylmalonic acid. Neurochem. Int. 40 (2002) 593-601
31. da Silva C.G., Ribeiro C.A., Leipnitz G., Dutra-Filho C.S., Wyse A.T.S., Wannmacher C.M., Sarkis J.J., Jakobs C., and Wajner M. Inhibition of cytochrome c oxidase activity in rat cerebral cortex and human skeletal muscle by D-2-hydroxyglutaric acid in vitro. Biochim. Biophys. Acta 1586 (2002) 81-91
32. Hughes B.P. A method for the estimation of serum creatine kinase and its use in comparing creatine kinase and aldolase activity in normal and pathological sera. Clin. Chim. Acta 7 (1962) 597-603
33. da Silva C.G., Bueno A.R., Schuck P.F., Leipnitz G., Ribeiro C.A., Rosa R.B., Dutra-Filho C.S., Wyse A.T.S., Wannmacher C.M., and Wajner M. Inhibition of creatine kinase activity from rat cerebral cortex by D-2-hydroxyglutaric acid in vitro. Neurochem. Int. 44 (2004) 45-52
34. +-ATPase activity in cerebral cortex of rats. NeuroReport 11 (2000) 1010-1014
35. 2+-stimulated ATPase activity. Anal. Biochem. 157 (1986) 375-380
36. Dutra-Filho C.S., Wajner M., Wannmacher C.M., Gassen E., Candiago R.H., Wilhelms A.M., and de Malfussi H.F. 2-Hydroxybutyrate and 4-hydroxybutyrate inhibit CO2 formation from labeled substrates by rat cerebral cortex. Biochem. Soc. Trans. 23 (1995) 228S
37. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-267
38. Mori A., Kohno M., Masumizu T., Nosa Y., and Packer I. Guanidino compounds generate reactive oxygen species. Biochem. Mol. Biol. Int. 40 (1996) 135-143
39. Hiramatsu M. A role for guanidino compounds in the brain. Mol. Cell. Biochem. 244 (2003) 57-62
40. Rustin P., and Rötig A. Inborn errors of complex II-unusual human mitochondrial diseases. Biochim. Biophys. Acta 1553 (2002) 117-122
41. Yousef M.I., El Hendy H.A., El-Demesdash F.M., and Elagamy E.I. Dietary zinc deficiency induced-changes in the activity of enzymes and the level of free radicals, lipids and protein electrophoretic behavior in growing rats. Toxicology 175 (2002) 223-234
42. Wolosker H., Panizzutti R., and Englender S. Inhibition of creatine kinase by S-nitrosoglutathione. FEBES Lett. 392 (1996) 274-276
43. Saransaari P., and Oja S.S. Taurine and neural cell damage. Amino Acids 19 (2000) 509-526
44. Ames B.N., Shigenaga M.K., and Hagen T.M. Oxidants, antioxidants and the degenerative diseases of aging. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 7915-7922
45. Burton G.W., Wronska U., Stone L., Foster D.O., and Ingold K.U. Biokinetics of dietary RRR-a-tocopherol in the male guinea-pig at three dietary levels of vitamin C and two levels of vitamin E. Lipids 25 (1990) 199-210
46. Frei B., Stocker R., England L., and Ames B.N. Ascorbate: the most effective antioxidant in the blood. Adv. Exp. Med. Biol. 264 (1990) 155-163
47. Carr A., and Frei B. Does vitamin C act as a pro-oxidant under physiological conditions?. FASEB J. 13 (1999) 1007-1024
48. Gupta R.C., Win T., and Bittner S. Taurine analogues; a new class of therapeutics: retrospect and prospects. Cur. Med. Chem. 12 (2005) 763-771
49. +-ATPase activity due to ozone exposure or cholesterol enrichment. J. Nutr. Sci. Vitaminol. 41 (1995) 627-634